Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 11—November 2017
Research

Drug-Resistant Tuberculosis among Children, China, 2006–2015

Ning-ning Tao, Xiao-chun He, Xian-xin Zhang, Yao Liu, Chun-bao Yu, and Huai-chen LiComments to Author 
Author affiliations: Shandong Provincial Hospital affiliated to Shandong University, Jinan, China (N.-N. Tao, Y. Liu, H.-C. Li); Baoji Central Hospital, Baoji, China (X.-C. He); Shandong Provincial Chest Hospital, Jinan (X.-X. Zhang, C.-B. Yu)

Main Article

Figure 2

Overall first-line drug resistance for INH, RIF, EMB, and SM in primary cases of tuberculosis in children, Shandong Province, China, 2006–2015. The χ2 and linear regression results are shown in Table 3. EMB, ethambutol; INH, isoniazid; RIF, rifampin; SM, streptomycin.

Figure 2. Overall first-line drug resistance for INH, RIF, EMB, and SM in primary cases of tuberculosis in children, Shandong Province, China, 2006–2015. The χ2 and linear regression results are shown in Table 3. EMB, ethambutol; INH, isoniazid; RIF, rifampin; SM, streptomycin.

Main Article

Page created: October 16, 2017
Page updated: October 16, 2017
Page reviewed: October 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external